Reuters logo
BRIEF-Jeevan Scientific Technology says DCGI approves Hyderabad bioequivalence study centre
December 21, 2016 / 8:15 AM / in 10 months

BRIEF-Jeevan Scientific Technology says DCGI approves Hyderabad bioequivalence study centre

Dec 21 (Reuters) - Jeevan Scientific Technology Ltd

* Study centre approved by office of Drug Control General, on 16-Dec-2016 for a period of three years

* Says approval of bioavailability/bioequivalence study centre at B-17, tie, phase-II, Balanagar, Hyderabad Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below